Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin calcium for refractory giant cell tumor of bone
jRCTs041250199Recruiting
- Start
- Mar 2026
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of heparin in Giant Cell Tumor of Bone (GCTB). Primary endpoint: Disease control rate at 12 weeks. Started Mar 2026; status: recruiting.
02
Drugs
heparin
03
Conditions
Giant Cell Tumor of Bone (GCTB)
Beyond the preview
Go deeper on jRCTs041250199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041250199.